Fresenius Seamless
Care of Delaware

an ESRD Seamless Care Organization

Fresenius Seamless Care of Delaware, LLC

Certain dialysis facilities in Delaware have chosen to participate in Fresenius Seamless Care of Delaware, an ESRD Seamless Care Organization (ESCO) in the Medicare Comprehensive ESRD Care model. See below for a listing of ESCO dialysis facilities in Delaware.

We’re Working to Improve Your Care

The goal of an ESCO is for dialysis facilities, nephrologists, and other health care providers to communicate and work together closely, so they can deliver high-quality care that meets the patient’s individual needs and preferences. ESCOs may be rewarded for providing their patients with higher quality, more coordinated care.

You Can Still Choose Any
Dialysis Facility, Doctor or Hospital

An ESCO Patient's Medicare benefits do not change. An ESCO is not a Medicare Advantage plan, a Health Maintenance Organization (HMO) plan, or an insurance plan of any kind.

ESCO Patients still have the right to use any dialysis facility, provider or hospital that accepts Medicare, at any time. A doctor may continue to recommend that an ESCO Patient see particular doctors or providers for their specific health needs, but it is always the patient's choice about which provider they use or dialysis facility or hospital they visit.

Questions or Concerns?

If you have questions or concerns, you can:

  • Call us at 1-844-209-9093, or bring it up next time you are in your provider’s office.
  • You can also call 1-800-MEDICARE (1-800-633-4227) and tell the representative you are calling about ESCOs.
  • TTY users should call 1-877-486-2048.

ESCO Leadership Team and Participants

Primary Contact

Eric Maaske

Fresenius Health Partners
eric.maaske@fmc-na.com
1-512-861-6409

Clinical Leadership Contact

Terry Ketchersid, MD

Integrated Care Group,
Fresenius Medical Care North America

terry.ketchersid@fmc-na.com
1-512-861-6409

Greg Garza

Integrated Care Group,
Fresenius Health Partners

Health Services

Scott Dickison

Integrated Care Group
Finance

Maria Radonova

Integrated Care Group,
Fresenius Health Partners

Actuary

Participants

Bio-Medical Applications Of Delaware, Inc.

Fresenius Medical Care Northern Delaware, LLC

Fresenius Medical Care Southern Delaware, LLC

National Medical Care, Inc.

Nephrology Associates, P.A.

  • Arun V. Malhotra
  • Carlos Machado
  • Colleen Reft
  • Collette J. Mehring
  • Daniel N. Coar
  • Feroz Abubacker Kaniyamparambil
  • Gayle Jones
  • Gerald J. Milan
  • Gertrude Findley-Christian
  • Helen Chang-DeGuzman
  • Jean Ann Yaccino
  • Jeffrey S. Cicone
  • Jose M. Saez
  • Karen Davis
  • Kristen Koechert
  • Laureen Eick-benson
  • Lindsey M. Slater
  • Manmeet Brar
  • Manthodi K. Faisal
  • Marie Renzi
  • Martin F. Gavin
  • Miroslaw P. Zdunek
  • Piyaporn Apivatanagul
  • Prayus T. Tailor
  • Rubeen K. Israni
  • Sangeetha Satyan
  • Sarah S. Torregiani
  • Sedelle Henderson-bamidele
  • Shadrienne Williams
  • Shalini G. Sehgal
  • Stephanie G. Gilibert
  • Svastijaya Daviratanasilpa
  • Tamara Newell
  • Theodore F. Saad
  • William J. Dahms, Jr.
  • Wilson Nino
  • Yamileth Wu-gerrard

Company

Fresenius Medical Care Holdings, Inc.
Fresenius Seamless Care
PO Box 162970
Austin, TX 78716-2970

Joint Ventures

WSKC Dialysis Services, Inc.
Fresenius Medical Care Lombard, LLC
Fresenius Medical Care Palatine, LLC
Fresenius Medical Care Elgin, LLC
Fresenius Medical Care Cicero, LLC
Fresenius Medical Care Naperbrook, LLC
Fresenius Medical Care Cna Kidney Centers, LLC
Fresenius Medical Care Northern Delaware, LLC
Fresenius Medical Care Southern Delaware, LLC
2217 East High Street, LLC

For more information about joint ventures,
call 844-209-9093.

Governing Body

Nephrology Associates, P.A. , William J. Dahms, Jr., D.O.
Nephrology Associates, P.A. , G. Jeff Milan, MD
Fresenius Kidney Care, Markeisha Jordan
Fresenius Health Partners, Edward Jones, MD
Independent Consumer Advocate, Tracy Woodson, Ed.D.

Quality Performance

Performance Year 2017 will be reported in winter 2018.

Financial Performance

Performance Year 2017 will be reported in winter 2018.